Aehr Test Systems Sees Unusually High Options Volume (NASDAQ:AEHR)

Aehr Test Systems (NASDAQ:AEHR) was the target of some unusual options trading activity on Tuesday. Stock investors bought 14,866 call options on the stock. This represents an increase of approximately 51% compared to the typical volume of 9,837 call options.

Wall Street Analyst Weigh In

AEHR has been the topic of several recent analyst reports. Freedom Capital raised Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Craig Hallum restated a “buy” rating and set a $125.00 price objective on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Oppenheimer initiated coverage on Aehr Test Systems in a research note on Thursday, September 10th. They set an “outperform” rating and a $120.00 target price on the stock. Jefferies Financial Group dropped their target price on Aehr Test Systems from $175.00 to $140.00 and set a “buy” rating on the stock in a report on Tuesday. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Aehr Test Systems in a research report on Tuesday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $118.75.

Aehr Test Systems Stock Performance

NASDAQ:AEHR opened at $65.11 on Wednesday. The stock’s 50 day moving average price is $82.04 and its 200 day moving average price is $74.09. Aehr Test Systems has a 52 week low of $18.70 and a 52 week high of $147.40.

Aehr Test Systems (NASDAQ:AEHR) last posted its earnings results on Monday, November 2nd. The semiconductor company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.17. The firm had revenue of $33.01 million during the quarter, compared to analysts’ expectations of $27.53 million. Aehr Test Systems had a negative net margin of 14.25% and a negative return on equity of 3.83%. On average, equities research analysts predict that Aehr Test Systems will post 0.45 earnings per share for the current year.

Insiders Place Their Bets

In other news, Director Laura Oliphant sold 1,717 shares of the stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $133.00, for a total value of $228,361.00. Following the completion of the sale, the director owned 16,100 shares in the company, valued at $2,141,300. This represents a 9.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Howard T. Slayen sold 5,700 shares of the stock in a transaction on Friday, August 14th. The shares were sold at an average price of $133.03, for a total value of $758,271.00. Following the completion of the sale, the director owned 140,667 shares of the company’s stock, valued at $18,712,931.01. The trade was a 3.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 87,475 shares of company stock worth $11,459,240 in the last quarter. Corporate insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Aehr Test Systems

A number of large investors have recently bought and sold shares of the business. BlackRock Inc. acquired a new stake in Aehr Test Systems in the 2nd quarter worth approximately $255,476,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Aehr Test Systems during the 2nd quarter worth $64,433,000. AWM Investment Company Inc. acquired a new position in Aehr Test Systems in the 2nd quarter valued at $36,004,000. Bard Associates Inc. acquired a new position in Aehr Test Systems in the 2nd quarter valued at $15,072,000. Finally, Penn Capital Management Company LLC bought a new position in Aehr Test Systems in the 2nd quarter worth $14,476,000. 69.69% of the stock is currently owned by institutional investors.

Key Headlines Impacting Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Aehr reported fiscal Q1 revenue of $33.0 million, ahead of the $27.5 million consensus, and EPS of $0.28 versus estimates of $0.11. The company cited robust AI-related semiconductor demand. Aehr Test Systems Stock Pops After Q1 Results: Here’s Why
• Positive Sentiment: Management raised its FY2027 revenue forecast to $150 million, above the $138.4 million analyst consensus and roughly triple FY2026 revenue. Effective backlog was $109.3 million as of November 1, supporting the growth outlook; the company also emphasized a goal of at least a 20% non-GAAP net income margin. Aehr Test Systems: 3 Key Takeaways for Long-Term Investors
• Neutral Sentiment: Options trading was unusually active, with call volume about 51% above its typical level—evidence of heightened trading interest, but not necessarily a lasting change in fundamentals.
• Negative Sentiment: Lake Street Capital cut its price target from $110 to $90, while Jefferies lowered its target from $175 to $140. Both firms kept Buy ratings, and their revised targets remain above the cited share price, but the reductions may temper expectations. Lake Street Capital recommendations Jefferies Financial Group recommendations

About Aehr Test Systems

Aehr Test Systems (NASDAQ: AEHR) develops and manufactures test and burn-in equipment used to qualify and screen semiconductor devices. Its systems are designed to identify manufacturing defects and reliability issues before chips are shipped to customers, helping semiconductor manufacturers improve production yields and product quality.

The company’s product portfolio includes the FOX family of semiconductor test systems, including the FOX-XP, FOX-NP and FOX-1P platforms. Aehr also provides wafer contactors, DiePak carriers and related test fixtures and software.